Furthermore, we assessed the presence of a pathogenic variant in BRCA1/2 in first-degree relatives, of a proven carrier, who had developed endometrial cancer without previous breast or synchronous ovarian cancer. This evidence concerns the gene BRCA1 and ovarian cancer.